SASKATOON, Saskatchewan, Sept. 29, 2025 (GLOBE NEWSWIRE) -- PHARMACORP RX INC. (“PharmaCorp” or the “Corporation”) (TSXV:PCRX) is pleased to announce that it has filed a preliminary short form base shelf prospectus with the securities commissions in each of the provinces of Canada, other than Quebec. The base shelf prospectus, when made final and effective, will allow the Corporation to ‎qualify the distribution by way of prospectus in Canada of up to $100 million of common shares, preferred ‎shares, warran ...

Core Insights - PharmaCorp RX Inc. has completed the acquisition of a 100% interest in a pharmacy business in Western Canada for a purchase price of $2,400,000, marking its fourth pharmacy acquisition [1] - The acquisition is part of PharmaCorp's strategic alliance with PharmaChoice Canada Inc. and aims to support pharmacists in their succession and exit strategies while preserving their legacy of care [2] - PharmaCorp currently operates four PharmaChoice bannered pharmacies and plans to continue acquiring both PharmaChoice and independently owned pharmacies across Canada [3] Company Overview - PharmaCorp operates under the TSX Venture Exchange with the symbol PCRX and is focused on expanding its pharmacy operations through strategic acquisitions [3] - The company emphasizes its commitment to helping pharmacy owners transition their businesses while maintaining community care standards [2]